MXPA03011769A - Derivados de heteroarilo novedosos, su preparacion y uso. - Google Patents

Derivados de heteroarilo novedosos, su preparacion y uso.

Info

Publication number
MXPA03011769A
MXPA03011769A MXPA03011769A MXPA03011769A MXPA03011769A MX PA03011769 A MXPA03011769 A MX PA03011769A MX PA03011769 A MXPA03011769 A MX PA03011769A MX PA03011769 A MXPA03011769 A MX PA03011769A MX PA03011769 A MXPA03011769 A MX PA03011769A
Authority
MX
Mexico
Prior art keywords
preparation
heteroaryl derivatives
novel heteroaryl
disorders
disorder
Prior art date
Application number
MXPA03011769A
Other languages
English (en)
Inventor
Andersen Kim
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of MXPA03011769A publication Critical patent/MXPA03011769A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Abstract

Un derivado de heteroarilo que tiene la formula (I). Los compuestos de la invencion son considerados utiles para el tratamiento de desordenes afectivos tales como desorden de ansiedad en general, desorden de panico, desorden compulsivo obsesivo, depresion, fobia social, y desordenes de la alimentacion, y desordenes neurologicos tales como psicosis.
MXPA03011769A 2001-06-29 2002-06-27 Derivados de heteroarilo novedosos, su preparacion y uso. MXPA03011769A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200101036 2001-06-29
PCT/DK2002/000435 WO2003002556A1 (en) 2001-06-29 2002-06-27 Novel heteroaryl derivatives, their preparation and use

Publications (1)

Publication Number Publication Date
MXPA03011769A true MXPA03011769A (es) 2004-04-02

Family

ID=8160598

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03011769A MXPA03011769A (es) 2001-06-29 2002-06-27 Derivados de heteroarilo novedosos, su preparacion y uso.

Country Status (27)

Country Link
US (2) US20040248883A1 (es)
EP (1) EP1399438B1 (es)
JP (1) JP2004535449A (es)
KR (1) KR20040019026A (es)
CN (1) CN1310909C (es)
AT (1) ATE312094T1 (es)
AU (1) AU2002344949B2 (es)
BG (1) BG108531A (es)
BR (1) BR0210401A (es)
CA (1) CA2451228A1 (es)
CZ (1) CZ2004156A3 (es)
DE (1) DE60207857T2 (es)
DK (1) DK1399438T3 (es)
EA (1) EA006203B1 (es)
ES (1) ES2252471T3 (es)
HK (1) HK1068622A1 (es)
HU (1) HUP0400344A2 (es)
IL (1) IL158828A0 (es)
IS (1) IS2425B (es)
MX (1) MXPA03011769A (es)
NO (1) NO326514B1 (es)
NZ (1) NZ529460A (es)
PL (1) PL365249A1 (es)
SI (1) SI1399438T1 (es)
SK (1) SK652004A3 (es)
UA (1) UA75407C2 (es)
WO (1) WO2003002556A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60206043T2 (de) * 2001-06-29 2006-06-29 H. Lundbeck A/S, Valby Neue indolderivate
US7504395B2 (en) * 2001-07-20 2009-03-17 Psychogenics, Inc. Treatment for attention-deficit hyperactivity disorder
AU2004256124B2 (en) * 2003-07-02 2011-04-28 Corus Pharma, Inc. Aztreonam L-lysine and methods for the preparation thereof
US7160888B2 (en) 2003-08-22 2007-01-09 Warner Lambert Company Llc [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia
DE602005016836D1 (de) 2004-11-26 2009-11-05 Janssen Pharmaceutica Nv Chotischer und anxiolytischer aktivität
EP2521723A1 (en) 2010-01-04 2012-11-14 Enantia, S.L. Process for the preparation of rivaroxaban and intermediates thereof
JP5567208B2 (ja) 2010-04-12 2014-08-06 ロッテ ケミカル コーポレーション オレフィン重合用触媒組成物およびこれを用いたポリオレフィンの製造方法
JP5567209B2 (ja) 2010-04-12 2014-08-06 ロッテ ケミカル コーポレーション オレフィン重合用担持触媒およびこれを用いたポリオレフィンの製造方法
ES2596718T3 (es) 2010-04-12 2017-01-11 Lotte Chemical Corporation Procedimiento de preparación de polipropileno usando un compuesto de metal de transición que contiene ligandos de ciclopentadienilo condensados con tiofeno
KR100986301B1 (ko) * 2010-04-12 2010-10-07 아주대학교산학협력단 테트라하이드로퀴놀린 유도체로부터 유래한 티오펜-축합고리 싸이클로펜타디에닐 4족 금속 화합물 및 이를 이용한 올레핀 중합
CN102892797A (zh) 2010-04-12 2013-01-23 湖南石油化学株式会社 使用包含噻吩稠合的环戊二烯基配体的过渡金属化合物制备烯烃-二烯共聚物的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2667068B1 (fr) * 1990-09-26 1994-09-09 Adir Nouvelles amines alkyl heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
DE60206043T2 (de) * 2001-06-29 2006-06-29 H. Lundbeck A/S, Valby Neue indolderivate

Also Published As

Publication number Publication date
PL365249A1 (en) 2004-12-27
DE60207857D1 (de) 2006-01-12
ATE312094T1 (de) 2005-12-15
NO20035673L (no) 2003-12-18
HUP0400344A2 (hu) 2004-09-28
CZ2004156A3 (cs) 2004-05-12
EA200400102A1 (ru) 2004-04-29
EA006203B1 (ru) 2005-10-27
BG108531A (bg) 2004-08-31
US20040248883A1 (en) 2004-12-09
CN1310909C (zh) 2007-04-18
KR20040019026A (ko) 2004-03-04
JP2004535449A (ja) 2004-11-25
AU2002344949B2 (en) 2007-05-24
ES2252471T3 (es) 2006-05-16
DK1399438T3 (da) 2006-04-18
DE60207857T2 (de) 2006-07-20
BR0210401A (pt) 2004-08-17
SK652004A3 (en) 2004-09-08
HK1068622A1 (en) 2005-04-29
CA2451228A1 (en) 2003-01-09
CN1520410A (zh) 2004-08-11
WO2003002556A1 (en) 2003-01-09
US20080027071A1 (en) 2008-01-31
NO326514B1 (no) 2008-12-22
SI1399438T1 (sl) 2006-04-30
IS2425B (is) 2008-10-15
IL158828A0 (en) 2004-05-12
IS7021A (is) 2003-11-10
NZ529460A (en) 2005-09-30
EP1399438A1 (en) 2004-03-24
US7393845B2 (en) 2008-07-01
EP1399438B1 (en) 2005-12-07
UA75407C2 (en) 2006-04-17
NO20035673D0 (no) 2003-12-18

Similar Documents

Publication Publication Date Title
HK1068622A1 (en) Novel heteroaryl derivatives, their preparation and use
HUS2100028I1 (hu) ERBB I. típusú receptor tirozinkináz-gátló N4-fenil-kinazolin-4-amin származékok és rokon vegyületeik a hiperproliferatív betegségek kezelésére
RS20120158A3 (en) Phenyl-piperazine Derivatives As Serotonin Resorption Inhibitors
WO2002064594A3 (en) 6-substituted pyrido-pyrimidines
YU63202A (sh) Derivati 2-okso-1-pirolidina, postupci za njihovo dobijanje i njihove upotrebe
MXPA04005456A (es) Derivados de acetileno que tienen actividad antagonistica de mglur5.
MXPA03010232A (es) Compuestos de arilsulfonamida, para el tratamiento de la obesidad, de la diabetes tipo ii y de trastornos del sistema nervioso central.
PL371127A1 (en) 6-aminomorphinane derivatives, method for the production and use thereof
AU2002256334A1 (en) Antidepressant azaheterocyclylmethyl derivatives of 2,3-dihydro-1,4-dioxino(2,3-f)quinoxaline
MXPA03011766A (es) Novedosos derivados de indol.
MXPA04005151A (es) Compuestos terapeuticos.
DE60204882D1 (de) Zykloalkenylsulfonamidderivate
MXPA04001855A (es) Derivados de sistemas de indan-1-ol c2-sustituidos, metodos para la produccion de los mismos y su uso como medicamentos.
TR200201679T2 (tr) Yeni heteroaril türevleri, bunların hazırlanması ve kullanımları.
WO2003005969A3 (en) Tetrahydropurinones as corticotropin releasing factor
ATE265418T1 (de) Neue substituierte 3-phenoxy- und 3- phenylalkyloxy-2-phenyl-propylamine
UA85198C2 (ru) Производные морфолина как ингибиторы повторного поглощения норэпинефрина
RS88803A (en) Novel-arylsulfonamide compounds for the treatment of obesity type ii diabetes and cns-disorders

Legal Events

Date Code Title Description
FG Grant or registration